Cardinal consolidates drug, device distribution with nuclear pharmacies
Wholesaler Cardinal Health is consolidating its network of pharmaceutical and medical device distribution centers and nuclear pharmacies to form the Healthcare Supply Chain Services segment, it said July 8. Also as part of the corporate restructuring, infusion, medication dispensing, respiratory care and infection protection will be handled under the newly created Clinical and Medical Products segment. Six-hundred positions will be eliminated as part of the restructuring, including 160 that are currently vacant. "Through this restructuring, we sharpen our focus on two distinct, large and growing segments of the health care industry by aligning our resources, reducing costs and helping to speed decision making for our customers," Cardinal CEO Kerry Clark said in a release
You may also be interested in...
ABHI’s Phil Brown believes the future of UK device regulation will be innovation-friendly and patient-responsive system – but doesn’t expect easy alignment with the EU. See what he had to say.
Biologics license application is preferred route to market, but if emergency authorization is given it should happen with full transparency and be communicated in a clear manner to strengthen public confidence, National Vaccine Advisory Committee says.
With the meetings available on television, access can be assured for just about everyone, and the US FDA can avoid another gut punch to its credibility.